Lorenza Rimassa

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 74

Top Venues

Cancers

Liver international : official journal of the International Association for the Study of the Liver

Therapeutic advances in medical oncology

Journal of clinical medicine

Humanitas University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Humanitas University Oct 01 2019

Italy

Associate Professor of Medical Oncology :: Biomedical Sciences

Istituto Clinico Humanitas Jan 01 2011

Italy

Deputy Director :: Medical Oncology Unit - Humanitas Cancer Center

Istituto Clinico Humanitas Nov 01 2007 - Dec 31 2010

Italy

Head - Gastrointestinal Oncology :: Medical Oncology Unit

Istituto Clinico Humanitas Jan 01 2002 - Oct 31 2007

Italy

Consultant :: Medical Oncology Unit

Istituto Clinico Humanitas Jan 12 1998 - Dec 31 2001

Italy

Assistant :: Medical Oncology Unit

Fondazione IRCCS Istituto Nazionale dei Tumori Nov 10 1997 - Dec 12 1997

Italy

Research Fellow :: Medical Oncology B Division

Fondazione IRCCS Istituto Nazionale dei Tumori Sep 01 1994 - Oct 31 1997

Italy

Resident in Oncology :: Medical Oncology B Division

Ospedale San Raffaele Nov 01 1993 - Aug 31 1994

Italy

Resident in Oncology :: Internal Medicine Division

Publications

Valentina Zanuso, Angelo Pirozzi, Giulia Tesini, Lorenza Rimassa
Review of immune therapy in HCC: Where are we now and what is the future? Clinical liver disease 23 (1) (2024)
Valentina Zanuso, Angelo Pirozzi, Giulia Tesini, Lorenza Rimassa
Review of immune therapy in HCC: Where are we now and what is the future? Clinical liver disease 23 (1) (2024)
Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David James Pinato, Lorenza Rimassa
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? Therapeutic advances in medical oncology 15 (2023)
Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. Current oncology (Toronto, Ont.) 30 (4) (2023)
Margherita Rimini, Lorenzo Fornaro, Sara Lonardi, Monica Niger, Daniele Lavacchi, Tiziana Pressiani, Jessica Lucchetti, Guido Giordano, Andrea Pretta, Emiliano Tamburini, Chiara Pirrone, Ilario Giovanni Rapposelli, Anna Diana, Erika Martinelli, Ingrid Garajová, Francesca Simionato, Marta Schirripa, Vincenzo Formica, Caterina Vivaldi, Enrico Caliman, Mario Domenico Rizzato, Valentina Zanuso, Federico Nichetti, Lorenzo Angotti, Matteo Landriscina, Mario Scartozzi, Matteo Ramundo, Alessandro Pastorino, Bruno Daniele, Noemi Cornara, Mara Persano, Eleonora Gusmaroli, Riccardo Cerantola, Francesca Salani, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Lorenza Rimassa, Lorenzo Antonuzzo, Stefano Cascinu
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data. Liver international : official journal of the International Association for the Study of the Liver 43 (8) (2023)
Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David James Pinato, Lorenza Rimassa
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? Therapeutic advances in medical oncology 15 (2023)
Margherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, Lorenza Rimassa, Ester Oneda, Caterina Soldà, Pasqua Cito, Guglielmo Nasti, Daniele Lavacchi, Valentina Zanuso, Mario Domenico Rizzato, Alberto Zaniboni, Alessandro Ottaiano, Mara Persano, Noemi Cornara, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience. Therapeutic advances in medical oncology 15 (2023)
Irene Bargellini, Lorenza Rimassa, Gianluca Masi
SIRT and chemotherapy in unresectable iCCA: Ready to take off. Hepatology (Baltimore, Md.) (2023)
Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. Current oncology (Toronto, Ont.) 30 (4) (2023)
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia A M Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei-Chang Lee, Yi-Hsiang Huang, Bertram Bengsch, Dominic Bettinger, Yehia I Mohamed, Ahmed Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter Robert Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David James Pinato
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Valentina Zanuso, Angelo Pirozzi, Rita Balsano, Tiziana Pressiani, Lorenza Rimassa
Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Vincent Joerg, Bernhard Scheiner, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Martin Schönlein, Lorenz Kocheise, Ansgar Wilhelm Lohse, Samuel Huber, Henning Wege, Ahmed Kaseb, Yinghong Wang, Antony Mathew, Andrew Kuang, Mahvish Muzaffar, Yehia I Abugabal, Shadi Chamseddine, Samuel Phen, Jaekyung Cheon, Pei-Chang Lee, Lorenz Balcar, Anja Krall, Celina Ang, Linda Wu, Anwaar Saeed, Yi-Hsiang Huang, Bertram Bengsch, Lorenza Rimassa, Arndt Weinmann, Rudolf Stauber, James Korolewicz, Matthias Pinter, Amit G Singal, Hong Jae Chon, David J Pinato, Kornelius Schulze, Johann von Felden
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study. Hepatology communications 7 (11) (2023)
Tin-Yun Tang, Federico Nichetti, Benjamin Kaplan, Sara Lonardi, Filippo Pietrantonio, Lisa Salvatore, Caterina Vivaldi, Lorenza Rimassa, Filippo G De Braud, Mario Domenico Rizzato, Dean C Pavlick, Randy Chu, Anaemy Danner De Armas, Radwa Sharaf, Ethan S Sokol, Jordi Rodon Ahnert, Jeffery S Ross, Milind M Javle, Monica Niger
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia A M Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei-Chang Lee, Yi-Hsiang Huang, Bertram Bengsch, Dominic Bettinger, Yehia I Mohamed, Ahmed Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter Robert Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David James Pinato
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Tiziana Comito, Maria Massaro, Maria Ausilia Teriaca, Ciro Franzese, Davide Franceschini, Pierina Navarria, Elena Clerici, Luciana Di Cristina, Anna Bertolini, Stefano Tomatis, Giacomo Reggiori, Andrea Bresolin, Silvia Bozzarelli, Lorenza Rimassa, Cristiana Bonifacio, Silvia Carrara, Armando Santoro, Alessandro Zerbi, Marta Scorsetti
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study). Current oncology (Toronto, Ont.) 30 (7) (2023)
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia A M Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei-Chang Lee, Yi-Hsiang Huang, Bertram Bengsch, Dominic Bettinger, Yehia I Mohamed, Ahmed Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter Robert Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David James Pinato
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia A M Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei-Chang Lee, Yi-Hsiang Huang, Bertram Bengsch, Dominic Bettinger, Yehia I Mohamed, Ahmed Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter Robert Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David James Pinato
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa, Silvia Bozzarelli
Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. Current oncology (Toronto, Ont.) 30 (4) (2023)
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia A M Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei-Chang Lee, Yi-Hsiang Huang, Bertram Bengsch, Dominic Bettinger, Yehia I Mohamed, Ahmed Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter Robert Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David James Pinato
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC: an international observational study. Liver international : official journal of the International Association for the Study of the Liver (2022)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Silvia Bozzarelli, Nicola Personeni, Lorenza Rimassa
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
Flavio Milana, Simone Famularo, Antonio Luberto, Lorenza Rimassa, Marta Scorsetti, Tiziana Comito, Tiziana Pressiani, Ciro Franzese, Dario Poretti, Luca Di Tommaso, Nicola Personeni, Marcello Rodari, Vittorio Pedicini, Matteo Donadon, Guido Torzilli
Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients. Cancers 14 (16) (2022)
Chiara Masetti, Nicola Pugliese, Ludovica Lofino, Francesca Colapietro, Roberto Ceriani, Ana Lleo, Dario Poretti, Vittorio Pedicini, Stella De Nicola, Guido Torzilli, Lorenza Rimassa, Alessio Aghemo, Ezio Lanza
Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization. Journal of clinical medicine 12 (1) (2022)
Nicola Personeni, Tiziana Pressiani, Valentina Zanuso, Andrea Casadei-Gardini, Antonio D'Alessio, Martina Valgiusti, Vincenzo Dadduzio, Francesca Bergamo, Caterina Soldà, Mario Domenico Rizzato, Laura Giordano, Armando Santoro, Lorenza Rimassa
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment. Journal of personalized medicine 12 (10) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Chiara Masetti, Nicola Pugliese, Ludovica Lofino, Francesca Colapietro, Roberto Ceriani, Ana Lleo, Dario Poretti, Vittorio Pedicini, Stella De Nicola, Guido Torzilli, Lorenza Rimassa, Alessio Aghemo, Ezio Lanza
Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization. Journal of clinical medicine 12 (1) (2022)
Luca Vigano, Egesta Lopci, Luca Di Tommaso, Annarita Destro, Alessio Aghemo, Lorenza Rimassa, Luigi Solbiati, Arturo Chiti, Guido Torzilli, Francesco Fiz
Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study. Journal of clinical medicine 11 (18) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia A M Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei-Chang Lee, Yi-Hsiang Huang, Bertram Bengsch, Dominic Bettinger, Yehia I Mohamed, Ahmed Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter Robert Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David James Pinato
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver international : official journal of the International Association for the Study of the Liver (2022)
Chiara Masetti, Nicola Pugliese, Ludovica Lofino, Francesca Colapietro, Roberto Ceriani, Ana Lleo, Dario Poretti, Vittorio Pedicini, Stella De Nicola, Guido Torzilli, Lorenza Rimassa, Alessio Aghemo, Ezio Lanza
Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization. Journal of clinical medicine 12 (1) (2022)
Chiara Masetti, Nicola Pugliese, Ludovica Lofino, Francesca Colapietro, Roberto Ceriani, Ana Lleo, Dario Poretti, Vittorio Pedicini, Stella De Nicola, Guido Torzilli, Lorenza Rimassa, Alessio Aghemo, Ezio Lanza
Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization. Journal of clinical medicine 12 (1) (2022)
Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights. Journal of hepatocellular carcinoma 9 (2022)
Tiziana Comito, Mauro Loi, Ciro Franzese, Elena Clerici, Davide Franceschini, Marco Badalamenti, Maria Ausilia Teriaca, Lorenza Rimassa, Vittorio Pedicini, Dario Poretti, Luigi Alessandro Solbiati, Guido Torzilli, Roberto Ceriani, Ana Lleo, Alessio Aghemo, Armando Santoro, Marta Scorsetti
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360). Current oncology (Toronto, Ont.) 29 (11) (2022)
Mathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Wu, Celina Ang, Thomas U Marron, Arndt Weinmann, Peter R Galle, Dominic Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei-Chang Lee, Yi-Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J Pinato, Rohini Sharma
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 42 (11) (2022)
Sergio Muñoz-Martínez, Víctor Sapena, Alejandro Forner, Jordi Bruix, Marco Sanduzzi-Zamparelli, Jose Ríos, Mohamed Bouattour, Mohamed El Kassas, Cassia R G Leal, Tudor Mocan, Jean Charles Nault, Rogerio C P Alves, Helen L Reeves, Leonardo Gomes da Fonseca, Ignacio García-Juárez, David James Pinato, Maria Varela, Saleh A Alqahthani, Mário Reis Alvares-DA-Silva, Juan C Bandi, Lorenza Rimassa, Mar Lozano, Jesús M González-Santiago, Frank Tacke, Margarita Sala, María Anders, Anja Lachenmayer, Federico Piñero, Alex França, Maria Guarino, Alessandra Elvevi, Giuseppe Cabibbo, Markus Peck-Radosavljevic, Ángela Rojas, Mercedes Vergara, Chiara Braconi, Sonia Pascual-Bartolomé, Christie Perelló, Vivianne Mello, Carlos Rodríguez-Lope, Juan Acevedo, Rosanna Villani, Clemence Hollande, Valérie Vilgrain, Ahmed Tawheed, Carmem Ferguson Theodoro, Zeno Sparchez, Lorraine Blaise, Daniele E Viera-Alves, Robyn Watson, Flair J Carrilho, Carlos Moctezuma-Velazquez, Antonio D'Alessio, Massimo Iavarone, Maria Reig
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study. Liver international : official journal of the International Association for the Study of the Liver 42 (8) (2022)
Nicola Personeni, Laura Giordano, Angelica Michelini, Antonio D'Alessio, Antonella Cammarota, Silvia Bozzarelli, Tiziana Pressiani, Maria Giuseppina Prete, Maria Teresa Sandri, Sabine Stioui, Luca Germagnoli, Armando Santoro, Lorenza Rimassa, Rossana Mineri
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study. Journal of personalized medicine 12 (2) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
David J Pinato, Ahmed Kaseb, Yinghong Wang, Anwaar Saeed, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Uqba Khan, ChiehJu Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Francesca Benevento, Hannah Hildebrand, Tiziana Pressiani, Yehia I Abugabal, Nicola Personeni, Yi-Hsiang Huang, Lorenza Rimassa, Celina Ang, Thomas Marron, David J Pinato
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study. Journal for immunotherapy of cancer 8 (2) (2021)
Antonio D'Alessio, Lorenza Rimassa, Alessio Cortellini, David James Pinato
PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects. Journal of hepatocellular carcinoma 8 (2021)
Nicola Personeni, Tiziana Pressiani, Antonio D'Alessio, Maria Giuseppina Prete, Silvia Bozzarelli, Luigi Terracciano, Arianna Dal Buono, Antonio Capogreco, Alessio Aghemo, Ana Lleo, Romano Fabio Lutman, Massimo Roncalli, Laura Giordano, Armando Santoro, Luca Di Tommaso, Lorenza Rimassa
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors. Cancers 13 (22) (2021)
Antonio D'Alessio, Maria Giuseppina Prete, Antonella Cammarota, Nicola Personeni, Lorenza Rimassa
The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges. Journal of hepatocellular carcinoma 8 (2021)
Antonella Cammarota, Antonio D'Alessio, Tiziana Pressiani, Lorenza Rimassa, Nicola Personeni
Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma. Drugs & aging 38 (7) (2021)
Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Musharraf Navaid, Abdul Rafeh Naqash, Anuhya Gampa, Umut Ozbek, Junk-Yi Lin, Ylenia Perone, Bruno Vincenzi, Marianna Silletta, Anjana Pillai, Yinghong Wang, Uqba Khan, Yi-Hsiang Huang, Dominik Bettinger, Yehia I Abugabal, Ahmed Omar Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Luca Di Tommaso, Masatoshi Kudo, Arndt Vogel, Francesco A Mauri, Alessio Cortellini, Rohini Sharma, Antonio D'Alessio, Celina Ang, David James Pinato
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. Cancers 14 (1) (2021)
Ana Lleo, Francesca Colapietro, Patrick Maisonneuve, Monia Aloise, Vincenzo Craviotto, Roberto Ceriani, Lorenza Rimassa, Salvatore Badalamenti, Matteo Donadon, Vittorio Pedicini, Alessandro Repici, Luca Di Tommaso, Antonio Voza, Guido Torzilli, Alessio Aghemo
Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center. Cancers 13 (9) (2021)
Antonio D'Alessio, Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma. Expert review of anticancer therapy 21 (9) (2021)
Nicola Personeni, Valeria Smiroldo, Emilio Francesco Giunta, Maria Giuseppina Prete, Lorenza Rimassa, Giacomo Bregni, Francesco Sclafani
Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives. Cancers 13 (18) (2021)
Dominik Pfister, Nicolás Gonzalo Nuñez, Roser Pinyol, Olivier Govaere, Matthias Pinter, Marta Szydlowska, Revant Gupta, Mengjie Qiu, Aleksandra Deczkowska, Assaf Weiner, Florian Müller, Ankit Sinha, Ekaterina Friebel, Thomas Engleitner, Daniela Lenggenhager, Anja Moncsek, Danijela Heide, Kristin Stirm, Jan Kosla, Eleni Kotsiliti, Valentina Leone, Michael Dudek, Suhail Yousuf, Donato Inverso, Indrabahadur Singh, Ana Teijeiro, Florian Castet, Carla Montironi, Philipp K Haber, Dina Tiniakos, Pierre Bedossa, Simon Cockell, Ramy Younes, Michele Vacca, Fabio Marra, Jörn M Schattenberg, Michael E D Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D'Alessio, Nicola Personeni, Lorenza Rimassa, Ann K Daly, Bernhard Scheiner, Katharina Pomej, Martha M Kirstein, Arndt Vogel, Markus Peck-Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G Augustin, Adrian Billeter, Beat Müller-Stich, Hiroto Kikuchi, Dan G Duda, Fabian Kütting, Dirk-Thomas Waldschmidt, Matthias Philip Ebert, Nuh Rahbari, Henrik E Mei, Axel Ronald Schulz, Jane A McKeating, Nisar Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean-François Dufour, Thomas U Marron, Ahmed Kaseb, Masatoshi Kudo, Yi-Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N Marche, Thomas Decaens, David James Pinato, Roland Rad, Joachim C Mertens, Achim Weber, Kristian Unger, Rüdiger Klein, Susanne Roth, Zuzana Macek Jilkova, Manfred Claassen, Quentin M Anstee, Bjørt K Kragesteen, Percy A Knolle, Burkhard Becher, Josep M Llovet, Mathias F Heikenwälder
NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature 592 (7854) (2021)
Stefano Cascinu, Mario Scartozzi, Toshifumi Tada, Changhoon Yoo, Shigeo Shimose, Gianluca Masi, Sara Lonardi, Luca Giovanni Frassineti, Silvestris Nicola, Piscaglia Fabio, Takashi Kumada, Hyung-Don Kim, Hironori Koga, Caterina Vivaldi, Caterina Soldà, Atsushi Hiraoka, Yeonghak Bang, Masanori Atsukawa, Takuji Torimura, Kunihiko Tsuj, Ei Itobayashi, Hidenori Toyoda, Shinya Fukunishi, Lorenza Rimassa, Margherita Rimini, Stefano Cascinu, Alessandro Cucchetti
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Maria Giuseppina Prete, Antonella Cammarota, Antonio D'Alessio, Valentina Zanuso, Lorenza Rimassa
Current options and future directions of systemic therapy for advanced biliary tract cancer. Exploration of targeted anti-tumor therapy 2 (5) (2021)
Luca Vigano, Pio Corleone, Shadya Sara Darwish, Nicolò Turri, Simone Famularo, Lorenzo Viggiani, Lorenza Rimassa, Daniele Del Fabbro, Luca Di Tommaso, Guido Torzilli
Hepatic and Extrahepatic Colorectal Metastases Have Discordant Responses to Systemic Therapy. Pathology Data from Patients Undergoing Simultaneous Resection of Multiple Tumor Sites. Cancers 13 (3) (2021)
Chiun Hsu, Lorenza Rimassa, Hui-Chuan Sun, Arndt Vogel, Ahmed O Kaseb
Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab. Therapeutic advances in medical oncology 13 (2021)
Tomi Jun, Umut Ozbek, Sirish Dharmapuri, Camille Hardy-Abeloos, Huili Zhu, Jung-Yi Lin, Nicola Personeni, Tiziana Pressiani, Naoshi Nishida, Pei-Chang Lee, Chieh-Ju Lee, Hannah Hildebrand, Neil Nimkar, Sonal Paul, Petros Fessas, Muntaha Naeem, Dominik Bettinger, Uqba Khan, Anwaar Saeed, Yi-Hsiang Huang, Masatoshi Kudo, Lorenza Rimassa, Thomas U Marron, David J Pinato, Celina Ang
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma. Therapeutic advances in medical oncology 13 (2021)
David J Pinato, Petros Fessas, Alessio Cortellini, Lorenza Rimassa
Combined PD-1/VEGFR Blockade: A New Era of Treatment for Hepatocellular Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Riccardo Caccialanza, Emanuele Cereda, Catherine Klersy, Silvia Brugnatelli, Valeria Borioli, Alessandra Ferrari, Marilisa Caraccia, Federica Lobascio, Anna Pagani, Sara Delfanti, Giuseppe Aprile, Michele Reni, Lorenza Rimassa, Davide Melisi, Stefano Cascinu, Luca Battistini, Francesca Candiloro, Paolo Pedrazzoli
Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial. Therapeutic advances in medical oncology 12 (2020)
Lorenza Rimassa, Marcus-Alexander Wörns
Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 40 (8) (2020)
Lorenza Rimassa
Novel Therapies for Hepatocellular Carcinoma. Cancers 12 (10) (2020)
David J Pinato, Takahiro Kaneko, Anwaar Saeed, Tiziana Pressiani, Ahmed Kaseb, Yinghong Wang, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Chieh-Ju Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Hannah Hildebrand, Yehia I Abugabal, Celina Ang, Thomas U Marron, Uqba Khan, Nicola Personeni, Lorenza Rimassa, Yi-Hsiang Huang
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade. Cancers 12 (7) (2020)
Antonio D'Alessio, Nicola Personeni, Tiziana Pressiani, Silvia Bozzarelli, Valeria Smiroldo, Matteo Simonelli, Ana Lleo, Armando Santoro, Lorenza Rimassa
COVID-19 and liver cancer clinical trials: Not everything is lost. Liver international : official journal of the International Association for the Study of the Liver 40 (7) (2020)
Manlio Monti, Paolo Morgagni, Oriana Nanni, Massimo Framarini, Luca Saragoni, Daniele Marrelli, Franco Roviello, Roberto Petrioli, Uberto Fumagalli Romario, Lorenza Rimassa, Silvia Bozzarelli, Annibale Donini, Luigina Graziosi, Verena De Angelis, Giovanni De Manzoni, Maria Bencivenga, Valentina Mengardo, Emilio Parma, Carlo Milandri, Gianni Mura, Alessandra Signorini, Gianluca Baiocchi, Sarah Molfino, Giovanni Sgroi, Francesca Steccanella, Stefano Rausei, Ilaria Proserpio, Jacopo Viganò, Silvia Brugnatelli, Andrea Rinnovati, Stefano Santi, Giorgio Ercolani, Flavia Foca, Linda Valmorri, Dino Amadori, Giovanni Luca Frassineti
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers 12 (10) (2020)
Nicola Personeni, Ana Lleo, Tiziana Pressiani, Francesca Colapietro, Mark Robert Openshaw, Chara Stavraka, Athanasios Pouptsis, David James Pinato, Lorenza Rimassa
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options. Cancers 12 (11) (2020)
Ezio Lanza, Chiara Masetti, Gaia Messana, Riccardo Muglia, Nicola Pugliese, Roberto Ceriani, Ana Lleo de Nalda, Lorenza Rimassa, Guido Torzilli, Dario Poretti, Felice D'Antuono, Letterio Salvatore Politi, Vittorio Pedicini, Alessio Aghemo, null null
Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma. PloS one 15 (6) (2020)
Sandro Barni, Gerardo Rosati, Sara Lonardi, Nicoletta Pella, Maria Banzi, Maria G Zampino, Katia F Dotti, Lorenza Rimassa, Paolo Marchetti, Evaristo Maiello, Fabrizio Artioli, Daris Ferrari, Roberto Labianca, Paolo Bidoli, Alberto Zaniboni, Alberto Sobrero, Vincenzo Iaffaioli, Sabino De Placido, Gian Luca Frassineti, Andrea Ciarlo, Angela Buonadonna, Nicola Silvestris, Elena Piazza, Lorenzo Pavesi, Mauro Moroni, Mario Clerico, Massimo Aglietta, Paolo Giordani, Francesca Galli, Fabio Galli, Fausto Petrelli
Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial. Therapeutic advances in medical oncology 12 (2020)
David J Pinato, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher Sng, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Ricard Mesia, Elia Segui, Federica Biello, Daniele Generali, Salvatore Grisanti, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Anna Carbo, Riccardo Bruna, Sarah Benafif, Andrea Marrari, Rachel Wuerstlein, Maria Carmen Carmona-Garcia, Neha Chopra, Carlo Alberto Tondini, Oriol Mirallas, Valeria Tovazzi, Marta Betti, Salvatore Provenzano, Vittoria Fotia, Claudia Andrea Cruz, Alessia Dalla Pria, Francesca D'Avanzo, Joanne S Evans, Nadia Saoudi-Gonzalez, Eudald Felip, Myria Galazi, Isabel Garcia-Fructuoso, Alvin J X Lee, Thomas Newsom-Davis, Andrea Patriarca, David Garcia-Illescas, Roxana Reyes, Palma Dileo, Rachel Sharkey, Yien Ning Sophia Wong, Daniela Ferrante, Javier Marco-Hernandez, Anna Sureda, Clara Maluquer, Isabel Ruiz-Camps, Gianluca Gaidano, Lorenza Rimassa, Lorenzo Chiudinelli, Macarena Izuzquiza, Alba Cabirta, Michela Franchi, Armando Santoro, Aleix Prat, Josep Tabernero, Alessandra Gennari
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Cancer discovery (2020)
Álvaro Díaz-González, Marco Sanduzzi-Zamparelli, Leonardo Gomes da Fonseca, Giovan G Di Costanzo, Rogerio Alves, Massimo Iavarone, Cassia Leal, Rodolfo Sacco, Ana M Matilla, Manuel Hernández Guerra, Gabriel Aballay Soteras, Marcus-Alexander Wörns, Matthias Pinter, Maria Varela, Morten Ladekarl, Aline Lopes Chagas, Beatriz Mínguez, Juan I Arenas, Alessandro Granito, Yolanda Sánchez-Torrijos, Ángela Rojas, Carlos Rodríguez de Lope, Mario R Alvares-da-Silva, Sonia Pascual, Lorenza Rimassa, José L Lledó, Carlos Huertas, Bruno Sangro, Edoardo Giovanni Giannini, Manuel Delgado, Mercedes Vergara, Christie Perelló, Alberto Lue, Margarita Sala, Adolfo Gallego, Susanna Coll, Tania Hernáez, Federico Piñero, Gustavo Henrique Santos Pereira, Alex França, Juan Marín, Margarita Anders, Vivianne Mello, Mar Lozano, Jean Charles Nault, Josemaría Menéndez, Ignacio García Juárez, Jordi Bruix, Maria Reig
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis. Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Robin Kate Kelley, Tim Meyer, Lorenza Rimassa, Philippe Merle, Joong-Won Park, Thomas Yau, Stephen L Chan, Jean-Frederic Blanc, Vincent C Tam, Albert Tran, Vincenzo Dadduzio, David W Markby, Rajesh Kaldate, Ann-Lii Cheng, Anthony B El-Khoueiry, Ghassan K Abou-Alfa
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Nicola Personeni, Tiziana Pressiani, Lorenza Rimassa
Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma. Health science reports 3 (1) (2020)
Chiara Porta, Francesca Maria Consonni, Sara Morlacchi, Sabina Sangaletti, Augusto Bleve, Maria Grazia Totaro, Paola Larghi, Monica Rimoldi, Claudio Tripodo, Laura Strauss, Stefania Banfi, Mariangela Storto, Tiziana Pressiani, Lorenza Rimassa, Silvia Tartari, Alessandro Ippolito, Andrea Doni, Giulia Soldà, Stefano Duga, Viviana Piccolo, Renato Ostuni, Gioacchino Natoli, Vincenzo Bronte, Fiorella Balzac, Emilia Turco, Emilio Hirsch, Mario Paolo Colombo, Antonio Sica
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs. Cancer research 80 (13) (2020)
Filippo Pietrantonio, Riccardo Lobefaro, Maria Antista, Sara Lonardi, Alessandra Raimondi, Federica Morano, Stefania Mosconi, Lorenza Rimassa, Sabina Murgioni, Andrea Sartore-Bianchi, Gianluca Tomasello, Raffaella Longarini, Gabriella Farina, Fausto Petrelli, Stefania Gori, Giovanni Randon, Salvatore Corallo, Filippo Pagani, Vincenzo Guarini, Federica Palermo, Antonia Martinetti, Marco Macagno, Ludovic Barault, Federica Perrone, Elena Tamborini, Massimo Milione, Federica Di Nicolantonio, Massimo Di Maio, Giovanni Fucà, Maria Di Bartolomeo, Filippo de Braud
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (5) (2019)
Francesco Saverio Mennini, Andrea Marcellusi, Gianluca Fabiano, Lorenza Rimassa, Armando Santoro, Nicola Personeni
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer. Future oncology (London, England) 15 (18) (2019)
Silvia Bozzarelli, Lorenza Rimassa, Laura Giordano, Simona Sala, Maria Chiara Tronconi, Tiziana Pressiani, Valeria Smiroldo, Maria G Prete, Paola Spaggiari, Nicola Personeni, Armando Santoro
Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND). Future oncology (London, England) 15 (35) (2019)
Cristina Travelli, Francesca Maria Consonni, Sabina Sangaletti, Mariangela Storto, Sara Morlacchi, Ambra A Grolla, Ubaldina Galli, Gian Cesare Tron, Paola Portararo, Lorenza Rimassa, Tiziana Pressiani, Massimiliano Mazzone, Rosalinda Trovato, Stefano Ugel, Vincenzo Bronte, Claudio Tripodo, Mario P Colombo, Armando A Genazzani, Antonio Sica
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells. Cancer research 79 (8) (2019)
Tommaso Cavalleri, Andrea Sartore-Bianchi, Gianluca Basso, Giuseppe Celesti, Fabio Grizzi, Paola Bossi, Luana Greco, Calogero Pitrone, Emanuele Valtorta, Gianluca Mauri, Mauro Truini, Filippo Gustavo Dall'Olio, Giovanni Brandi, Luigi Ricciardiello, Valter Torri, Lorenza Rimassa, Salvatore Siena, Alberto Mantovani, Alberto Malesci, Luigi Laghi, null null
Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression. Cancer immunology research 7 (5) (2019)
Lorenza Rimassa, Tiziana Pressiani, Nicola Personeni, Armando Santoro
Regorafenib for the treatment of unresectable hepatocellular carcinoma. Expert review of anticancer therapy 17 (7) (2017)

Lorenza Rimassa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lorenza Rimassa